Catimanan, Rizal -.
HRN: 26-38-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/23/2024
12/29/2024
IV
220 Mg
Q6H
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes